A new generation of medical devices is set to have a profound impact on American health – and wealth.
You see, I know from detailed research and analysis that more than 100,000 people in the U.S. die each year from bad reactions to drugs.
That's more than three times as many as those who die from all street drugs, including heroin.
Fortunately, a better way is just on the horizon.
Indeed, new "microchip medicine" technology by itself could save as many as 1 million American lives roughly every decade.
It's proof that you should never throw a good idea away. The two researchers behind this new breakthrough device first thought of it more than 15 years ago.
Now, their tiny product appears headed to produce some big results.
Microchip Medicine Breakthroughs
To reach this breakthrough, the two Massachusetts Institute of Technology (MIT) researchers teamed up with their colleagues at a small biotech firm called MicroCHIPS. The firm is privately held.
But if it ever goes public, you'll want to keep an eye on MicroCHIPS as a potentially winning investment – one that also will benefit millions.
Here's why: A new study showed that doctors can safely implant a small semiconductor into a patient's body.
In turn, doctors can program the microchip to deliver the correct doses of medicine at precisely the right times.
The chips operate wirelessly and can be programmed as needed to change doses. How cool is this?
This particular study involved providing drugs to women who suffer from osteoporosis. But I believe it could be used with dozens of diseases treated with prescription drugs.
But don't take my word for it. Here is what MIT professor Robert Langer had to say.
"You could literally have a pharmacy on a chip," Langer told the college journal MIT News.
His partner, Michael Cima, also addressed one of my main concerns, which is patient safety. Of course, he didn't directly discuss saving lives.
But he seems to understand instinctively how difficult it is for patients on multiple drugs to keep taking them in the correct sequence.
The microchip technology avoids the "compliance issue completely," Cima says, adding that it "points to a future where you have fully automated drug regimens."
Bingo. That's what I'm talking about.
In the very near future, your doctor will no longer bother with injections or pills. Instead, he will implant a microchip in your body.
That chip – or something similar – will deliver the right drugs at the right time.
To keep you safe, your doctor will get alerts from your body delivered wirelessly from your chip directly to his computer network.
Some obstacles remain, however.
Right now, the chips can only deliver 20 doses. But MicroCHIPS is working on a system that will increase that number to 100.
In fact, I predict that in the next few years, patients will receive several different prescribed drugs from a single chip.
After all, we live in an Era of Radical Change in which devices get ever more powerful as they get smaller.
Microchip Medicine Means Longer Lifespans
The combination of new computers, software and biotech will combine to help us live well beyond 100 with much better physical and mental health.
More breakthroughs are on the way…
Take the "crab" that can eat the cancer inside your body.
They designed these medical bots to enter a patient's stomach through an endoscope. It's a small camera guided by a wire.
A surgeon then guides the "medbot" to the cancer. Once on target, the bot uses a pincer to cut out the cancer, which the robotic arm then removes.
This could have a major medical impact across the board. That includes those stricken with stomach cancer.
Stomach cancer remains a leading killer worldwide and is common in East Asia. Researchers said the robot recently helped remove early-stage stomach cancers in five patients in India and Hong Kong.
The Singapore team also reported three other benefits – no scars, less time in surgery and reduced risks of infection.
Bad Vision?… There's an App for That
Finally, your smart phone may soon be able to give you an eye exam. This new $2 app comes to you from MIT Professor Ramesh Raskar.
He notes that some 2 billion people in the world need glasses. But millions in developing nations can't get their eyes checked.
His Netra system uses an eyepiece that clips to the smart phone. It then measures your vision.
Raskar's team says Netra uses cheap optics and interactive software to replace costly laser-based gear.
He talked about Netra's potential in a YouTube video. He says the team is working with eye clinics and eye-glass firms to get the new tech out in the field.
So, you can see that at the very least, some of this new technology will improve human health. Others will help us live much longer.
Still others will no doubt save millions of lives someday.
And remember, as investors we will benefit as well, since some new medical devices are bound to result in some very profitable stock plays.
In the future issues I'll discuss them.
News and Related Story Links:
- Money Morning:
How the "New Cold War" with China Will Change America's Future
- Money Morning:
A Hundred Billion Reasons to Invest in Robotics Technology
- Money Morning:
3D Chips Will Deliver an Era of Radical Change
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.